Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
Condition(s):Non-small Cell Lung CancerLast Updated:July 7, 2020Recruiting
Hide Studies Not Open or Pending
Condition(s):Non-small Cell Lung CancerLast Updated:July 7, 2020Recruiting
Condition(s):Juvenile Myelomonocytic Leukemia; Neurofibromatosis Type 1Last Updated:April 14, 2021Recruiting
Condition(s):Low-grade Glioma; Plexiform Neurofibroma; Central Nervous System GliomaLast Updated:March 22, 2021Recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:December 3, 2019Terminated
Condition(s):Stage IV Melanoma; Stage III MelanomaLast Updated:December 17, 2020Recruiting
Condition(s):Malignant Neoplasms of Digestive Organs; Colorectal Cancer; Colon CancerLast Updated:April 2, 2020Active, not recruiting
Condition(s):Bronchial NeoplasmsLast Updated:July 15, 2019Recruiting
Condition(s):Advanced Lymphoma; Advanced Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm; Refractory Lymphoma; Refractory Malignant Solid Neoplasm; Refractory Plasma Cell MyelomaLast Updated:March 12, 2021Active, not recruiting
Condition(s):Advanced Lymphoma; Advanced Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm; Refractory Lymphoma; Refractory Malignant Solid Neoplasm; Refractory Plasma Cell MyelomaLast Updated:April 2, 2021Active, not recruiting
Condition(s):Metastatic Pancreatic Carcinoma; Stage II Pancreatic Cancer; Stage IIA Pancreatic Cancer; Stage IIB Pancreatic Cancer; Stage III Pancreatic Cancer; Stage IV Pancreatic Cancer; Unresectable Pancreatic CarcinomaLast Updated:November 13, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.